Welcome to our dedicated page for Agilon Health news (Ticker: AGL), a resource for investors and traders seeking the latest updates and insights on Agilon Health stock.
agilon health, inc. provides a healthcare services platform that partners with primary care physician groups and health systems to transition senior patient care to a value-based Total Care Model. Company updates commonly cover Medicare Advantage members and ACO model beneficiaries on the agilon platform, payor contract economics, market exits, clinical programs, data and technology investments, and operating discipline within a Medicare-centric capitated care model.
News also includes quarterly and annual financial results, revenue, medical margin and Adjusted EBITDA guidance, conference participation, and governance changes such as CEO appointments and board membership. Recurring disclosures tie membership trends, payor alignment and clinical execution to the economics of agilon’s physician partnerships.
Agilon Health has appointed Mat Varghese as its new chief people officer, effective October 11, 2021. Reporting to CEO Steve Sell, he will focus on employee development, growth, and talent acquisition strategies. Varghese brings nearly 20 years of HR leadership experience from firms like R1 RCM and General Electric. He succeeds Chris Casler, who left to pursue other opportunities. The company aims to transform healthcare for seniors by empowering primary care physicians.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
agilon health, inc. (NYSE: AGL) has announced a public offering of 17,000,000 shares of its common stock, priced at $30.00 per share, from certain selling stockholders. The offering is expected to close on September 14, 2021, pending customary conditions. Notably, agilon health will not receive any proceeds from this secondary offering. The underwriters have the option to purchase an additional 2,550,000 shares. Leading managers for this offering include J.P. Morgan, Goldman Sachs, and BofA Securities.
agilon health, inc. (NYSE: AGL) has announced a secondary public offering of 17,000,000 shares by certain selling stockholders, with a potential additional 2,550,000 shares for underwriters. The company will not receive proceeds from the offering, which has lead managers including J.P. Morgan, Goldman Sachs, and BofA Securities. Additionally, 714,011 shares held by company officers and directors will be available for sale due to a waiver of a lockup restriction. A registration statement with the SEC has been filed, and details can be obtained from the lead managers.
agilon health, inc. (NYSE: AGL) will participate in two major investor conferences: the Wells Fargo Virtual Healthcare Conference on September 9 at 10:40 AM ET and the Morgan Stanley 19th Annual Global Healthcare Conference on September 10 at 5:00 PM ET. Both events will include fireside chat presentations, accessible through a live webcast on agilon's investor relations website. The company focuses on improving healthcare for seniors by empowering primary-care physicians with essential support and resources, fostering healthier communities and better patient care.
Agilon Health, Inc. (NYSE: AGL) reported a 70% increase in total revenue to $499 million for Q2 2021, with a year-to-date growth of 56%. Membership rose by 45% year-over-year, reaching approximately 181,700 members. However, the company faced a net loss of $299 million, a significant rise from the $8 million loss in 2020, primarily due to $275 million in stock compensation expenses. Medical Margin decreased to $55 million, and adjusted EBITDA was negative $2 million compared to a positive $14 million last year. Outlook for Q3 2021 projects revenues between $450 million and $453 million.